广告
加载中

200人干翻欧美巨头 冲击10倍增长 85后博士造出“隐形冠军”

杨洁 2026-05-20 10:15
杨洁 2026/05/20 10:15

邦小白快读

EN
全文速览

本文介绍了85后双博士后王天创办程天科技,扎根外骨骼赛道近十年,带领200人团队打破欧美巨头垄断,冲击2026年十倍销售增长的创业历程,核心干货如下:

1. 外骨骼行业的发展方向:未来外骨骼将从被动防护支撑的护膝头盔,进化为智能装备,最终会成为统一承载智能设备算力和储能的随身AI能量站,形态接近人机融合的共生体,未来有望普及到大众日常场景。

2. 程天科技的成功路径:不追风口选长期刚需,先卡位医疗康复赛道啃下合规硬骨头建立壁垒,再向消费场景下放技术,打造全周期产品矩阵,不打价格战,专注卷效率、智能和服务。

3. 当前发展成果:2025年推出首款消费级产品,覆盖专业助老和科技潮玩两大市场,无锡自建工厂已经投产,2026年预计实现十倍销售增长,赛道整体进入快速爆发期。

程天科技的发展路径为外骨骼赛道品牌商提供了很多可参考的干货,核心内容整理如下:

1. 行业消费趋势:当前外骨骼行业进入关键转折期,B端医疗康复需求稳定,2025年人形机器人爆发带动消费级市场起爆,专业助老、景区租赁、户外潮玩三大需求增长,中国3亿60岁以上老人的助行、关节防护需求是庞大刚性市场。

2. 产品研发经验:抓住海外巨头只覆盖单点需求、产品笨重操作复杂的缺口,打造从重症失能到健康增强的全周期产品矩阵,消费级产品做减法简化结构降成本,实现扫码自动匹配参数,三五分钟即可上机,使用效率远超海外产品。

3. 竞争策略参考:依托中国高效供应链和工程师红利,和海外品牌定同价位,不靠价格战取胜,靠功能创新和效率优势竞争;发展路径上先做B端医疗建立合规壁垒,再拓展C端,稳扎稳打降低风险。

针对外骨骼赛道的从业者,本文透露了多项市场机会、发展经验与风险提示,核心干货整理如下:

1. 政策与市场机会:2018年国家正式将外骨骼定为医疗器械,后续多地出台鼓励国产采购的政策,给国产外骨骼企业留出了珍贵的发展窗口;当前行业还处于品类定义期,玩家越多品类渗透越快,整体增长空间大,消费级市场2026年就有望实现十倍增长,入场机会充足。

2. 需求层面的机会:消费级市场拆分为两大刚需基本盘,一是3亿老人的专业助行需求,上下楼、日常遛弯、关节防护都是刚性需求;二是科技潮玩需求,景区登山、旅行的体能增强需求已经起爆。

3. 可学习经验与风险提示:经验是避开非刚需风口,锁定长期普适刚需方向,先建立技术和合规壁垒再拓展C端,卷服务和智能不卷价格;风险提示是外骨骼属于慢行业,医疗合规、临床验证都要以年为单位投入,需要做好长期布局的准备,不能急功近利。

外骨骼行业的爆发给生产制造类工厂带来了新的商业机会,也提供了不少发展启示,核心干货如下:

1. 产品生产与设计需求:外骨骼分为B端医疗和C端消费两大方向,医疗端产品对合规性、精度要求高,需要覆盖从重症卧床到居家康复全周期的不同产品;C端消费产品要求简化结构、控制成本,做到极简好用,对生产的成本控制和精度都提出了新要求。

2. 商业机会:随着消费级外骨骼市场爆发,行业销量从千万级向亿级跨越,头部品牌已经开始投产自建工厂,上下游配套工厂,包括核心零部件、结构件、组装加工等环节都将获得大量新增订单需求,市场空间广阔。

3. 数字化与电商转型启示:外骨骼属于智能硬件,对生产的精度和规模化交付要求高,头部企业选择自建工厂掌控制造环节,说明制造能力是复杂智能硬件的核心竞争力,工厂需要推进数字化升级,才能适配行业需求,跟上行业增长红利。

外骨骼行业当前处于快速增长的关键转折期,给各类相关服务商带来了新的业务机会,核心干货整理如下:

1. 行业发展趋势:外骨骼行业已经从早期的B端医疗场景,拓展到C端消费场景,随着具身智能、人形机器人产业的爆发,大众认知快速提升,行业增速明显加快,未来外骨骼有望成为普及性的日常智能装备,整体市场空间非常大。

2. 客户核心痛点:行业发展早期缺乏统一的国标行标,医疗端的合规申报、临床验证难度大;海外产品操作复杂、价格高,无法覆盖康复全周期需求;C端市场爆发后,品牌方面临产能不足、成本高、场景落地难等问题,需要外部支持。

3. 可布局的解决方案方向:可以开展合规咨询、临床资源对接、行业标准制定协作等服务,帮助硬科技创业团队解决医疗端的核心痛点;针对C端品牌,可提供供应链优化、生产对接、场景运营落地等服务,帮助品牌降低成本,快速打开市场。

外骨骼赛道的爆发给各类平台带来了新的增长机会,核心干货整理如下:

1. 品牌方对平台的核心需求:消费级外骨骼当前需要对接线下场景和C端用户,专业助老类产品需要对接养老机构、社区场景,潮玩租赁类产品需要对接景区、户外休闲场景,同时需要电商、内容平台帮助教育市场,提升大众品类认知。

2. 平台可布局的方向:可以针对性开展外骨骼品牌招商,针对不同场景对接资源:在户外景区、休闲平台开辟外骨骼租赁服务入口,在养老服务平台接入专业助行产品,对接3亿老人的刚性需求,在电商平台开设外骨骼专属专区,扶持品牌成长。

3. 运营管理与风险规避:当前品类处于普及初期,平台可以联合品牌开展科普种草,共同培育市场;同时外骨骼属于医疗器械相关产品,平台需要严格审核品牌的合规资质,把好准入关,避免不合规产品流入市场,把控政策与合规风险。

本文呈现了中国外骨骼行业最新的发展动态,对产业研究具备较高的参考价值,核心干货整理如下:

1. 产业新动向:全球外骨骼赛道原本形成美日德巨头鼎立的格局,海外龙头上市后留下了无法覆盖康复全周期、产品体验差的缺口,当前依托中国政策支持、供应链优势和工程师红利,国产外骨骼实现了突破,2025年后人形机器人爆发带动消费级市场兴起,行业进入品类定义权竞争的关键转折期。

2. 值得研究的新发展模式:程天科技探索出了一条不同于硬科技企业的路径,不追短期风口,先卡位医疗康复刚需,花多年时间啃下合规、临床验证的硬骨头建立技术壁垒,再将技术自然下放到消费级场景,这种稳扎稳打的路径对硬科技创业具备标杆意义。

3. 政策启示:早期国家明确外骨骼的医疗器械身份,出台鼓励国产采购的政策,给国产企业留出了宝贵的地基发展期,帮助企业建立了护城河,证明明确新兴产业身份、支持国产创新的政策,能够有效推动本土硬科技产业发展,对后续相关产业政策制定有参考价值。

返回默认

声明:快读内容全程由AI生成,请注意甄别信息。如您发现问题,请发送邮件至 run@ebrun.com 。

我是 品牌商 卖家 工厂 服务商 平台商 研究者 帮我再读一遍。

Quick Summary

This article tells the entrepreneurial story of Wang Tian, a post-1985 double postdoctoral fellow who founded Chengjiang Robotics (Chengtian Technology). Over nearly a decade dedicated to the exoskeleton industry, he has led a 200-person team to break the monopoly held by Western giants and is targeting 10x revenue growth by 2026. Key takeaways are as follows:

1. Future development direction of the exoskeleton industry: Exoskeletons will evolve from passive protective supports (such as knee braces and helmets) to intelligent devices, and eventually become a portable AI energy hub that integrates computing power and energy storage for smart wearables. This form will eventually become a human-machine symbiosis, and is expected to become widespread in daily consumer scenarios.

2. Chengjiang Robotics' path to success: Instead of chasing short-term hype, the company focused on long-term rigid demand, first establishing an early foothold in the medical rehabilitation segment by overcoming the high barrier of regulatory compliance to build market moats. It then expanded its mature technology into consumer scenarios to build a full-cycle product portfolio, avoiding price competition and focusing instead on operational efficiency, intelligent functions, and user service.

3. Current progress and outlook: The company will launch its first consumer-grade product in 2025, targeting the senior assistance and tech enthusiast novelty markets. Its self-owned factory in Wuxi has already started production, and the company projects 10x revenue growth in 2026, as the entire exoskeleton industry enters a period of rapid expansion.

Chengjiang Robotics' growth path offers valuable actionable insights for brands in the exoskeleton industry. Key takeaways are as follows:

1. Consumer industry trends: The exoskeleton industry is currently at a critical inflection point. B2B demand from the medical and rehabilitation sector remains stable, and the boom in humanoid robots starting in 2025 is triggering rapid growth in the consumer market. Three key demand segments are seeing particularly strong growth: professional senior assistance, scenic spot rental, and outdoor tech recreation. China, with 300 million residents aged 60 and above, represents a huge, rigid market for walking assistance and joint protection.

2. Product R&D lessons: Western giants only serve niche, single-point needs with bulky, hard-to-operate products. Chengjiang Robotics leveraged this gap to build a full-cycle product portfolio covering use cases from severe disability support to healthy human performance enhancement. For consumer products, the company simplified product structures to cut costs, adding features like automatic parameter matching via QR code that allow users to get set up in three to five minutes, delivering far higher usability than competing overseas products.

3. Competitive strategy takeaways: Leveraging China's efficient supply chains and engineering talent pool, Chengjiang Robotics prices its products at parity with Western brands, and competes on functional innovation and efficiency advantages rather than price wars. On the growth front, the company first built compliance barriers through B2B medical operations before expanding into the consumer market, taking a steady approach that reduces business risk.

For industry practitioners looking to enter the exoskeleton track, this article shares multiple market opportunities, operational lessons, and risk warnings. Key takeaways are as follows:

1. Policy and market opportunities: In 2018, China formally classified exoskeletons as medical devices, followed by multiple local policies that encourage public procurement of domestically made products, creating a valuable window of opportunity for domestic exoskeleton companies. The industry is still in the category definition stage, meaning more market participants will accelerate category penetration and open up massive overall growth room. The consumer exoskeleton market is projected to see 10x growth as soon as 2026, leaving abundant entry opportunities for new players.

2. Demand-side opportunities: The consumer market can be split into two core rigid demand segments: First, professional walking assistance for China's 300 million seniors, covering rigid needs such as stair climbing, daily walking, and joint protection; second, novelty tech recreation, where demand for physical performance enhancement for mountain hiking and travel is already growing rapidly.

3. Actionable lessons and risk warnings: The key lesson is to avoid chasing non-essential hype and lock in long-term, universal rigid demand, building technical and compliance barriers first before expanding to the consumer market, and competing on service and intelligence rather than price. The core risk warning: Exoskeletons is a slow-cycling industry, where medical compliance and clinical validation require multi-year investments. Players must prepare for long-term布局 and avoid overzealous short-term pursuit of quick gains.

The boom in the exoskeleton industry has created new business opportunities and key growth insights for manufacturing facilities. Key takeaways are as follows:

1. Product manufacturing and design requirements: Exoskeletons fall into two major categories: B2B medical products and C2C consumer products. Medical products have strict requirements for compliance and precision, and need to cover different products for the entire rehabilitation cycle from severe bedridden care to home rehabilitation. Consumer products require simplified structures, controlled costs, and extreme ease of use, which puts forward new requirements for manufacturers' cost control and production precision.

2. Business opportunities: As the consumer exoskeleton market booms, industry-wide sales are growing from hundreds of millions of yuan to billions of yuan. Leading brands have already put self-owned factories into operation, which will bring large volumes of new order demand to upstream and downstream supporting factories, including core components, structural parts, assembly and processing, creating broad market space.

3. Insights for digital and e-commerce transformation: As a type of intelligent hardware, exoskeletons have high requirements for production precision and scalable delivery. Leading players' choice to build their own factories to control manufacturing links confirms that manufacturing capability is the core competitive advantage for complex intelligent hardware. Factories need to push forward with digital upgrades to meet industry demand and capture the growth dividend of the sector.

The exoskeleton industry is currently at a critical inflection point of rapid growth, bringing new business opportunities for a wide range of relevant service providers. Key takeaways are as follows:

1. Industry development trends: The exoskeleton industry has expanded from its early B2B medical use cases to C2C consumer scenarios. Fueled by the boom in embodied intelligence and the humanoid robot industry, public awareness has grown rapidly and the industry's growth rate has accelerated significantly. In the future, exoskeletons are expected to become a widely adopted daily intelligent device, with very large overall market potential.

2. Core customer pain points: In the early stage of industry development, there are no unified national or industry standards. Compliance application and clinical validation for medical products are particularly challenging. Overseas products have complex operation and high price points, and cannot cover the full-cycle rehabilitation demand. After the C2B market boom, brands also face pain points including insufficient production capacity, high costs, and difficulty in on-the-ground scenario expansion that require external support.

3. Solution directions that can be explored: Service providers can offer compliance consulting, clinical resource matching, and industry standard collaboration to help hard tech startups solve core pain points in the medical segment. For consumer brands, providers can deliver supply chain optimization, production matching, and scenario operation and expansion services to help brands cut costs and enter the market quickly.

The boom in the exoskeleton track has created new growth opportunities for all types of platforms. Key takeaways are as follows:

1. Core demands from brands to platforms: Consumer-grade exoskeletons currently need connections to offline scenarios and C2C end users. Professional senior assistance products need connections to elder care institutions and community scenarios, while recreational rental products need partnerships with scenic spots and outdoor leisure platforms. Brands also need e-commerce and content platforms to help educate the market and improve public awareness of the new category.

2. Directions platforms can explore: Platforms can launch targeted recruitment programs for exoskeleton brands and match resources for different use cases: open exoskeleton rental service portals on outdoor and scenic spot leisure platforms, integrate professional walking assistance products into elder care service platforms to tap the rigid demand of China's 300 million seniors, and launch dedicated exoskeleton sections on e-commerce platforms to support brand growth.

3. Operation management and risk mitigation: Since the category is still in the early adoption stage, platforms can co-develop popular science and influencer marketing programs with brands to co-build the market. At the same time, as exoskeletons are medical device-related products, platforms must strictly audit brands' compliance qualifications to control entry access, prevent non-compliant products from entering the market, and mitigate policy and compliance risks.

This article presents the latest development dynamics of China's exoskeleton industry, with high reference value for industrial research. Key takeaways are as follows:

1. New industrial trends: The global exoskeleton track was long dominated by a triopoly of giants from the U.S., Japan and Germany. After these overseas leaders went public, they left unaddressed gaps: they failed to cover the full rehabilitation cycle, and delivered poor product user experiences. Today, supported by Chinese policy incentives, supply chain advantages and engineering talent dividends, domestic exoskeleton players have achieved major breakthroughs. The humanoid robot boom after 2025 has spurred the rise of the consumer market, and the industry has entered a critical inflection point of competition for category definition power.

2. A new developmental model worth studying: Chengjiang Robotics has explored a path different from most hard tech startups: instead of chasing short-term market hype, it first established a foothold in the rigid demand medical rehabilitation sector, spent years overcoming the tough challenges of compliance and clinical validation to build technical barriers, and then naturally extended its technology to consumer scenarios. This steady, step-by-step path sets a benchmark for hard tech entrepreneurship.

3. Policy implications: Early on, the Chinese government clarified exoskeletons' classification as medical devices and rolled out policies to encourage domestic procurement, giving domestic companies valuable time to build their foundational capabilities and helping them establish market moats. This proves that policies that clarify the classification of emerging industries and support domestic innovation can effectively drive the development of local hard tech industries, and provides a valuable reference for future industrial policy formulation.

Disclaimer: The "Quick Summary" content is entirely generated by AI. Please exercise discretion when interpreting the information. For issues or corrections, please email run@ebrun.com .

I am a Brand Seller Factory Service Provider Marketplace Seller Researcher Read it again.

你有没有想过,在未来,人们可能会有另一层“皮肤”,就像漫威电影里的毒液共生体一般,可以自由变换大小,在你需要的时候自然浮现,像衣服一样无感穿在身上,赋予力量,然后悄然隐去。

这是程天科技创始人、CEO王天对外骨骼机器人终局的想象。在他的描摹中,未来的外骨骼不再是绑在身上的支架,而更像是纳米机器人构成的共生体,有独立智慧,和人体深度协作。它的最终形态,更像是人的新器官。

这种设想,并非完全天马行空。在程天科技的办公室里,王天给出了一个更落地的解释:广义上的外骨骼其实早就存在,例如护膝、头盔,提供的是被动的防护和支撑。随着具身智能技术的成熟,外骨骼的形态正在拓展到智能装备,接下来便是人类的能源载体和算力载体。

“现在消费者身上的智能装备越来越多,眼镜、耳机、手机、手环,这些设备的算力和能源都是分散的。”王天认为,外骨骼可以统一承载智能设备的算力和储能,成为随身AI能量站。

这是中国外骨骼行业中一个较少被人提及的视角,而程天科技,已经在这条赛道上走了近十年。

在具身智能与AI浪潮席卷的2026年,这家并非“杭州六小龙”之列的企业,却以惊人的速度闯入大众视野。2026年3月,程天科技刚刚完成亿元级B+轮融资,一年之内连续两轮融资,资本市场正在加速押注外骨骼赛道。

王天的创业之路,从一开始就带着极客的热爱与理想主义底色。

这个出生于黑龙江医学世家的创业者,从小在医院大院长大,见过太多因行动能力衰退而陷入困境的人。父亲要求王天必须读完博士,他就一路念到哈尔滨工程大学与加拿大卡尔顿大学的双博士后,但始终没有学医,兴趣一直在机器人身上。用他自己的话说:“康复医疗方案没有最优解,选错了方案,可能导致病人出问题,压力太大,可机器人造不好可以再造,修一修也能用。”

大学时期,他便钻进学校地下室,用旧书包和旧拖鞋做成背带和踏板,“手搓”出了第一个外骨骼原型。当时的动机很简单,他爱打篮球,想做个东西帮自己跳得更高,梦想是能灌篮。

真正走向创业之路后,这个方向很快被团队否定了,助跳外骨骼不够刚需,好玩的东西很多,但用户不一定真的需要。2016年,这群平均年龄不到26岁的极客做了一个关键抉择:他们回到原点,选择了一个更慢、更重,但确定性更强的场景——医疗康复。

“家里有至亲生病,看着他行走能力越来越弱,到最后完全走不了,衰退速度非常快。”正是这段切身体验,加上从小在医院目睹病人的无助,让他们锁定了康复赛道。“它不够酷,发展也慢,但一定是每个家庭都需要的。”

放眼全球,外骨骼赛道早已形成美、日、德鼎立的格局。美国Ekso Bionics从军工转康复,凭先发优势占据院端;以色列品牌Rewalk(现更名为Lifeward)依赖保险支付切入家庭场景;日本Cyberdyne从地震救灾起步,深耕养老辅助。这些品牌在2015—2016年前后上市,一度被视为行业标杆,却共同留下一个致命缺口:产品笨重、操作复杂,只覆盖链条上的某个单点,无法贯穿从重症失能到康复的全周期。

这恰恰给了中国外骨骼机器人崛起的时机。

2018年,外骨骼被国家正式明确为医疗器械,随后多地鼓励国产采购。这一段珍贵的地基期,为程天科技筑起了第一道护城河。叠加中国的高效供应链和工程师红利,这让程天敢于在全球市场与海外品牌定同一价位,并在功能和创新上与之掰手腕。

“我们不是在做国产替代,是在走自己的路。”在采访中,王天介绍了中外外骨骼机器人的差异,海外设备调试一台至少半小时,且耗费大量人工,而程天的产品,扫码就能自动匹配病历、身高和腿长,三五分钟上机。

但外骨骼终究是个“慢行业”。医疗器械合规、临验证、标准制定,每一环都以年为单位计时。

从2018年到2024年,程天科技一直在B端场景里深耕。作为创新医疗器械,早年间国内没有国标也没有行标,王天的团队就和检测所一起定义了中国外骨骼的强制执行标准。

从重症卧床、院内康复到居家辅助、社区养老,再到轻量化或个人无动力支撑,程天科技提供了覆盖从失能到健康增强的产品矩阵,去解决行业长久以来“缺人、太贵、难规模化”的问题。

2025年,成为外骨骼的出圈元年。人形机器人的爆发带火了整个供应链,大众认知也被影视作品、品牌概念款彻底打开,消费级市场迎来爆发。景区租赁、银发助行、户外潮玩三大场景同时起爆。

同年3月,程天科技正式推出第一款消费级产品“易行髋关节助力外骨骼”,发力C端市场。

在采访中,王天把消费级市场拆成两个基本盘:一个是专业助老,中国60岁以上老人超过3亿,他们是需要自主行动的庞大群体,上下楼、遛弯、关节防护,每一个日常场景都是刚需;另一个是科技潮玩,以景区租赁为切口,让普通人在登山、旅行中突破体能极限。

“有些事,必须是人自己去做。”在王天看来,外骨骼能拓展人的边界,比如让体能一般的父母陪孩子登山,让老人自由上下楼,让普通人不留遗憾。这种能力,才是消费级外骨骼的灵魂。

据介绍,程天科技的消费级机器人销售规模从早年的几百万元跃升至去年数千万元,并在2026年直冲数亿量级,预计将达到十倍增长。

所有的宏大图景,终要落在工厂、产能、交付和效率上。随着C端市场的爆发,目前,程天科技的无锡自建工厂已正式投产。在王天看来,做复杂智能硬件企业,必须自己掌控制造,机器人的终局就是制造,而消费级产品的核心就是做减法,简化结构、降低成本,做到极简好用。

复盘程天科技的发展路径,不难看出一条坚定的主线:

一是选长期、刚需、足够普适的方向,不追风口,不卷红海,卡位医疗康复的底层需求;

二是先啃下医疗合规这块最硬的骨头,用临床数据和认证标准建立壁垒,再向消费和工业场景做自然的技术下放;

三是全周期覆盖从重症到健康增强,用产品矩阵和AI化服务解决康复过程中的需求;

四是不打价格战,卷效率、卷智能、卷服务、卷场景理解。

随着具身智能市场爆发,傅利叶智能、大艾机器人、迈步机器人加速抢占市场,海尔也开始入局外骨骼赛道。谈及竞争,王天称并不畏惧更多玩家入场,反而笃信玩家越多,品类渗透越快,消费者越早受益。

“过去一万年,工具飞速进化,人类本身却没太大变化,我们太需要技术手段迭代升级,外骨骼就是人机融合的方案。”王天表示。

采访结束时,当被问及对程天科技的终极期待是什么。王天说了一句话:最高光的时刻不是公司上市,而是有一天从窗户望下去,街上有半数人身上都穿着外骨骼。“不一定是程天的产品,但我推动了这件事。”

这当然还很远,但路径已经隐约可见。从医疗康复端积累的临床数据和步态理解,到消费级产品在真实生活场景里的高频使用反馈,从更宏观的视角看,中国外骨骼行业到了关键转折期,玩家们可以主动去定义这个品类的底层逻辑与未来形态,这场定义权的竞争,才刚刚开始。

注:文/杨洁,文章来源:天下网商(公众号ID:txws_txws),本文为作者独立观点,不代表亿邦动力立场。

文章来源:天下网商

广告
微信
朋友圈

这么好看,分享一下?

朋友圈 分享

APP内打开

+1
+1
微信好友 朋友圈 新浪微博 QQ空间
关闭
收藏成功
发送
/140 0